All News
Filter News
Found 806,061 articles
-
Hormone-Boosting Drug May Help Treat Frailty
1/28/2009
-
Novartis Corporation (JOBS) Sees Tougher 2009, Even as Q4 Profit Jumps
1/28/2009
-
Roche (JOBS) Heirs Extend Majority Shareholding Deal
1/28/2009
-
Gen-Probe Incorporated and Novartis Corporation Agree to Extend and Expand Blood Screening Collaboration
1/28/2009
-
Becton, Dickinson and Company Q1 Profit Tops Wall Street, Ups '09 View
1/28/2009
-
Amylin Pharmaceuticals, Inc. (JOBS) Q4 Loss Widens on Charges, Falling Byetta Sales
1/28/2009
-
Effects Of Concussion Last Decades, University Of Montreal Study Suggests
1/28/2009
-
IVAX Diagnostics, Inc. Announces Appointment of Charles R. Struby as Chief Executive Officer and President
1/28/2009
-
BaroFold, Inc. Appoints J. William Freytag, Ph.D. as President and Chief Executive Officer
1/28/2009
-
Taro Pharmaceutical Industries Ltd. Receives Final FDA Approval for Lamotrigine Tablets ANDA
1/28/2009
-
Alfacell Provides ONCONASE(R) NDA Submission Update
1/28/2009
-
Positron Corporation’s Joint Venture Submits FDA 510(k) for its Attrius(TM) PET Scanner
1/28/2009
-
Roche's Mabthera Seeks Approval In The EU For Treatment In Most Common Form Of Leukaemia In Adults
1/28/2009
-
Nuvo Research Inc. Announces Successful Completion Of All Pennsaid(R) Studies
1/28/2009
-
Cell Therapeutics, Inc. Release: Pixantrone Increases Progression-Free Survival by 81% Compared to Standard Chemotherapeutic Agents in Phase III Relapsed Aggressive non-Hodgkin's Lymphoma Trial
1/28/2009
-
Medarex, Inc. Announces Allowance of Investigational New Drug Application for Company's First Antibody-Drug Conjugate, MDX-1203
1/28/2009
-
Can-Fite BioPharma Completed Patient Enrollment for the Phase II Trial in Dry Eye Syndrome with CF101
1/28/2009
-
Addex Pharmaceuticals Successfully Completes ADX48621 Phase I Program
1/28/2009
-
Medarex, Inc. Says FDA Approves Testing of Cancer Drug
1/28/2009
-
Cannasat Therapeutics Inc. And IntelGenx Corp. Reach Key Milestone
1/28/2009